Cassava on first trial had higher response % than anavex.. but anavex super duper responders reaponded better.
Cassava appears from latest tea leaf to positively effect 62.5% of population -125. / 200 - very positively( we don’t know how positively yet just like we don’t know how well 50mg affected early AD but we know it was strong enough data to bring up the combined lesser effect of 30Mg to Clinically meet endpoints - primary and secondary..
Does cellular hmoeoataiss automatically correct the issues which cassavas drug fixes?
Maybe cassava drug will make anavex drug more effective as well.. right?